• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Biotech

Stem cell dollars: California leads the way

By
Fortune Editors
Fortune Editors
,
Brett Krasnove
Brett Krasnove
and
Brett Krasnove
Brett Krasnove
Down Arrow Button Icon
By
Fortune Editors
Fortune Editors
,
Brett Krasnove
Brett Krasnove
and
Brett Krasnove
Brett Krasnove
Down Arrow Button Icon
September 28, 2012, 7:03 AM ET
Ray and Dagmar Dolby Regeneration Medicine Building UCSF, San Francisco Benefactor: Ray and Dagmar Dolby $36 million Science: It required $123 million to build this architectural marvel alongside a bedrock hill. UCSF researchers are renowned for the progress they're making on potential therapies for neurologic diseases like multiple sclerosis.

Ray and Dagmar Dolby Regeneration Medicine Building UCSF, San Francisco Benefactor: Ray and Dagmar Dolby $36 million Science: It required $123 million to build this architectural marvel alongside a bedrock hill. UCSF researchers are renowned for the progress they're making on potential therapies for neurologic diseases like multiple sclerosis.

Sue and Bill Gross Stem Cell Research Center UC Irvine, Irvine, Calif. Benefactor: Sue and Bill Gross $10 millionScience: This center used green and recycled building materials to achieve LEED Platinum certification. The center's marquee projects involve the exploration of treatments for the effects of Alzheimer's disease and spinal-cord injury.

Sue and Bill Gross Stem Cell Research Center UC Irvine, Irvine, Calif. Benefactor: Sue and Bill Gross $10 millionScience: This center used green and recycled building materials to achieve LEED Platinum certification. The center's marquee projects involve the exploration of treatments for the effects of Alzheimer's disease and spinal-cord injury.

The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA, Los AngelesBenefactor: The Eli and Edythe Broad Foundation $20 million Science:UCLA researchers are making demonstrable inroads against melanoma. With a series of CIRM grants, they've progressed from basic research and are poised to embark on clinical trials to treat the deadly form of skin cancer.

The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA, Los Angeles Benefactor: The Eli and Edythe Broad Foundation $20 million Science: UCLA researchers are making demonstrable inroads against melanoma. With a series of CIRM grants, they've progressed from basic research and are poised to embark on clinical trials to treat the deadly form of skin cancer.

The Lorry I. Lokey Stem Cell Research Building Stanford University, Palo Alto Benefactor: Lorry I. Lokey $75 million Science:Stanford University has received more than $260 million in CIRM funding to date, part of which went toward constructing a striking facility complete with a (donated) two-ton Chihuly sculpture. Researchers here are finding new ways to battle cancer stem cells and develop therapies for neurologic diseases and stroke.

The Lorry I. Lokey Stem Cell Research Building Stanford University, Palo Alto Benefactor: Lorry I. Lokey $75 million Science: Stanford University has received more than $260 million in CIRM funding to date, part of which went toward constructing a striking facility complete with a (donated) two-ton Chihuly sculpture. Researchers here are finding new ways to battle cancer stem cells and develop therapies for neurologic diseases and stroke.

About the Authors
Fortune Editors
By Fortune Editors
See full bioRight Arrow Button Icon
By Brett Krasnove
See full bioRight Arrow Button Icon
By Brett Krasnove
See full bioRight Arrow Button Icon

Latest in

Big TechStreaming
Trump says Netflix-Warner Bros. deal ‘could be a problem’
By Hadriana Lowenkron, Se Young Lee and BloombergDecember 7, 2025
45 minutes ago
Big TechOpenAI
OpenAI goes from stock market savior to burden as AI risks mount
By Ryan Vlastelica and BloombergDecember 7, 2025
54 minutes ago
InvestingStock
What bubble? Asset managers in risk-on mode stick with stocks
By Julien Ponthus, Natalia Kniazhevich, Abhishek Vishnoi and BloombergDecember 7, 2025
1 hour ago
EconomyTariffs and trade
Macron warns EU may hit China with tariffs over trade surplus
By James Regan and BloombergDecember 7, 2025
1 hour ago
EconomyTariffs and trade
U.S. trade chief says China has complied with terms of trade deals
By Hadriana Lowenkron and BloombergDecember 7, 2025
1 hour ago
PoliticsCongress
Leaders in Congress outperform rank-and-file lawmakers on stock trades by up to 47% a year, researchers say
By Jason MaDecember 7, 2025
2 hours ago

Most Popular

placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
1 day ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
1 day ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
2 days ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
11 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.